P, Y., J, Z., X, W., C, J., & L, C. (2025). Evidence-based investigation of the efficacy and safety of venetoclax-containing regimens versus chemoimmunotherapy in chronic lymphocytic leukemia. Naunyn-Schmiedeberg's archives of pharmacology, 398(8), 10429. https://doi.org/10.1007/s00210-025-03911-8
Chicago Style (17th ed.) CitationP, Yao, Zhang J, Wang X, Jia C, and Cheng L. "Evidence-based Investigation of the Efficacy and Safety of Venetoclax-containing Regimens Versus Chemoimmunotherapy in Chronic Lymphocytic Leukemia." Naunyn-Schmiedeberg's Archives of Pharmacology 398, no. 8 (2025): 10429. https://doi.org/10.1007/s00210-025-03911-8.
MLA (9th ed.) CitationP, Yao, et al. "Evidence-based Investigation of the Efficacy and Safety of Venetoclax-containing Regimens Versus Chemoimmunotherapy in Chronic Lymphocytic Leukemia." Naunyn-Schmiedeberg's Archives of Pharmacology, vol. 398, no. 8, 2025, p. 10429, https://doi.org/10.1007/s00210-025-03911-8.